Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Search Results for: label/Biomet – Page 2

Medical Device Makers Face FCPA Investigation

The Securities and Exchange Commission is investigating possible violations of the U.S. Foreign Corrupt Practices Act by Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc. They’ve all made announcements about the SEC’s action and deny any violations. The companies make replacement implants for knees, hips and the spine and […]

Read More »

FCPA enforcement report for Q2 2016

During the second calendar quarter, there were four corporate FCPA enforcement actions and eight individual resolutions (seven related to Direct Access Partners). There were also three guilty pleas by individuals.

Read More »

Compliance Officer (Bilfinger SE – Mannheim, Germany)

Job Title: Compliance Officer
Company: Bilfinger SE
Location: Mannheim, Germany
 
Tasks 
The Compliance Officer will lead efforts to promote compliance at all levels of Bilfinger and contribute to the continuous improvement of the compliance program and the underlying elements. She/he will support the business to implement and apply compliance-related policies, controls and procedures. The position holder will report to the Chief Compliance Officer and will be part of the global Compliance Leadership Team.

Read More »

Tough Medicine For Medical Device Makers

The Securities and Exchange Commission said in October this year it is investigating possible violations of the U.S. Foreign Corrupt Practices Act by the leading manufacturers of orthopedic implants. Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc. all made announcements about the SEC’s investigation and denied violating any laws. […]

Read More »

Advice for companies after conflict minerals ruling

Tungsten, courtesy of Enough Project via YouTubeAn appellate court Monday struck down part of the conflict-minerals rule, leaving SEC-reporting companies wondering what disclosures to include in their conflict minerals reports due on May 31.

Read More »